Unfortunately other commitments have delayed this week’s
post, but here goes. There are two cases
being heard this week in the High Court.
On Tuesday 28 May 2013 the Court heard argument in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd.
In that case Hoechst AG held a patent for a compound called
leflunomide. That patent, which expired
in 2004, claimed a “method for the treatment of inflammations, rheumatic complaints
and multiple sclerosis by administering to the patient an effective dose” of
leflunomide. In 1994 Hoechst AG applied
for a patent (expiring in 2014) in which it claimed “A method of preventing or
treating a skin disorder, wherein the skin disorder is psoriasis, which
comprises administering to the patient an effective dose” of lelunomide. Apotex has marketed a generic form of
leflunomide, for which it has TGA approval and copied the respondent’s patient
information. The respondents sought to
restrain Apotex from marketing its generic leflunomide for psoriasis, claiming
it breached the patent. The High Court
has thus been called upon to rule on whether or not a method of treatment of
the human body is capable of being a patentable invention, or alternatively
whether a claim for a subsequent use of a previously known product claims a
patentable invention. The hearing continues tomorrow.
On Thursday, 30 May 2013 the Court
will hear argument in the appeals in Issa v The Queen and Elias v The Queen. The Court will consider the extent of the
principle in R v Liang & Li,
whereby a sentencing court imposing a penalty for a State offence is required
to have regard to the fact that the accused could have been charged with a
different offence under State law that carried a lesser penalty. At issue in the appeal is whether or not in
sentencing a person for a State offence, the principle in R v Liang & Li requires a court to take into account that the
person could have been charged with a similar offence for the same conduct
under a Commonwealth law which carried a lesser maximum penalty.
No comments:
Post a Comment